Karachi, Pakistan – 4 March 2026 – On the occasion of World Obesity Day, Novo Nordisk and the Ministry of National Health Services, Regulations and Coordination (MoNHSRC) came together to highlight the urgent need for coordinated action to address obesity as a growing public health priority in Pakistan.
The joint engagement, held at the Ministry’s premises on 4 March 2026, was attended by Dr. Malik Mukhtar Ahmad Bharath, Federal State Minister for Health, H.E. Maja Mortensen, Danish Ambassador to Pakistan, Hamed Yaqoob Sheikh, Secretary MoNHSRC, Dr Abdul Wali Khan, DG Health, Hasnain Ahmad, Head of Public Affairs, Novo Nordisk, and other senior officials from the Ministry, Embassy and Novo Nordisk. The gathering underscored a shared commitment to advancing awareness, strengthening dialogue, and promoting a science-based approach to obesity prevention and care.
In Pakistan, the prevalence of overweight and obesity has been steadily rising, affecting both adults and children and placing additional pressure on the healthcare system. But despite its scale and impact, obesity remains widely misunderstood and often stigmatized creating barriers to timely diagnosis and appropriate care. Against this backdrop, World Obesity Day served as an important moment for dialogue between Novo Nordisk and the Ministry of National Health Services, Regulations and Coordination, bringing renewed focus to science-based, long-term solutions.
Commenting on the occasion, the minister stated, “Obesity is emerging as a serious public health concern in Pakistan, contributing significantly to the burden of non-communicable diseases. Addressing it requires a comprehensive national approach that combines prevention, early intervention and improved access to care. We welcome continued engagement with stakeholders to strengthen awareness and build healthier communities across the country.”
The MoNHSRC secretary said, “Obesity is not simply about lifestyle, it is a complex, chronic disease influenced by biology, environment and social factors. The MoNHSRC, through PM diabetes program, is committed to improve understanding, reduce stigma and expand access to effective, person-centred care.”
Sharing her views, the Danish Ambassador to Pakistan, said “It is encouraging to see constructive dialogue taking place in Pakistan around long-term, evidence-based solutions. Partnerships that promote knowledge-sharing and innovation are essential in supporting sustainable health outcomes.”
Commenting on the occasion, Hasnain Ahmad, Head of Public Affairs, Novo Nordisk said, “At Novo Nordisk, turning the tide on obesity is a global priority. With 30 years of dedicated research in obesity and a century of leadership in chronic disease care, Novo Nordisk is committed to supporting Pakistan’s efforts to improve understanding, reduce stigma and expand access to effective, person-centred care.”
About Novo Nordisk
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries.
